Antidepressants, Antipsychotics, Anxiolytics - Buschmann, Helmut / Holenz, Jörg / Párraga, Antoni / Torrens, Antoni / Vela, José Miguel (eds.)
Marktplatzangebote
Gebraucht bestellen
Ein Angebot für € 49,95 €
  • Gebundenes Buch

Antidepressants and related psychiatric drugs are the most important prescription drugs worldwide, accounting for a market volume of 20 billion US$ per year. This handbook provides a complete and detailed overview of all currently available psychiatric drugs, covering more than 250 different compounds. Particular features include: the most important information on the chemistry, pharmacology and therapeutic use of a given drug a special layout with margin notes and compound structures allowing for quick and easy access to the desired information Written by drug developers from the…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Antidepressants and related psychiatric drugs are the most important prescription drugs worldwide, accounting for a market volume of 20 billion US$ per year. This handbook provides a complete and detailed overview of all currently available psychiatric drugs, covering more than 250 different compounds.
Particular features include:
the most important information on the chemistry, pharmacology and therapeutic use of a given drug
a special layout with margin notes and compound structures allowing for quick and easy access to the desired information
Written by drug developers from the pharmaceutical industry, novel drugs currently under development and new methods of treatment are listed side by side with classical drugs, allowing a direct comparison of traditional and innovative therapeutic approaches.
Autorenporträt
The editors all work for the Spanish-based pharmaceutical company Esteve, a world leader in neuropharmaceuticals.
Helmut Buschmann is the research director of Esteve, in charge of the discovery and development of new active substances for a variety of neurological disorders. He was formerly the head of research at Gruenenthal, a Germany-based pharma company that also specialized in neuropharmaceuticals. During his time at Gruenenthal, he published a widely acclaimed book on analgesics that pioneered the integrated approach followed also in his most recent book.